← Back to Search

Dressing

PermeaDerm® for Thermal Burns

N/A
Recruiting
Led By David Greenhalgh, M.D.
Research Sponsored by Stedical Scientific, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights

Study Summary

This trial will test the effectiveness of two different types of dressings for treating partial thickness burns.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reepithelialization
Secondary outcome measures
Adverse Events
Alternate therapy
Dressing Changes Required
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PermeaDerm®Experimental Treatment1 Intervention
N=34 Participants will receive application of PermeaDerm® as outlined in Directions for Use
Group II: Mepilex Ag®Active Control1 Intervention
Participants will receive application of Mepilex Ag® as outlined in Directions for Use.

Find a Location

Who is running the clinical trial?

Stedical Scientific, Inc.Lead Sponsor
David Greenhalgh, M.D.Principal InvestigatorUniversity of California, Davis

Media Library

Mepilex Ag (Dressing) Clinical Trial Eligibility Overview. Trial Name: NCT05084183 — N/A
Thermal Burns Research Study Groups: PermeaDerm®, Mepilex Ag®
Thermal Burns Clinical Trial 2023: Mepilex Ag Highlights & Side Effects. Trial Name: NCT05084183 — N/A
Mepilex Ag (Dressing) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05084183 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any availability for participants in this research experiment?

"This clinical trial, which was created on February 2nd 2022 and edited recently on June 21st 2022, is actively recruiting patients."

Answered by AI

What is the current enrollment of this research project?

"Affirmative. Clinicaltrials.gov features the study's posting, which was first introduced on February 2nd 2022 and modified most recently on June 21st 2022. This clinical trial is actively seeking 68 participants from a single medical site."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Evaluation of the Effectiveness of PermeaDerm® (PD) as Compared to Mepilex Ag®
2022. "Evaluation of the Effectiveness of PermeaDerm® (PD) as Compared to Mepilex Ag®". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05084183.
~21 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top